Scarica l'app Stockscreener
436.27
0.06%
0.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$436.03
Aprire:
$436.4
Volume 24 ore:
540.14K
Relative Volume:
2.16
Capitalizzazione di mercato:
$5.79B
Reddito:
$2.54B
Utile/perdita netta:
$259.78M
Rapporto P/E:
23.78
EPS:
18.3497
Flusso di cassa netto:
$377.12M
1 W Prestazione:
+3.66%
1M Prestazione:
-1.21%
6M Prestazione:
+1.40%
1 anno Prestazione:
-20.11%
Intervallo 1D:
$434.87
$449.00
Intervallo di 1 settimana:
$411.01
$449.00
Portata 52W:
$365.20
$562.76
Chemed Corp Stock (CHE) Company Profile
Nome
Chemed Corp
Settore
Industria
Telefono
(513)762-6690
Indirizzo
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
436.27 | 5.79B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-25 | Iniziato | Jefferies | Hold |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Buy |
| 2018-10-12 | Iniziato | BofA/Merrill | Buy |
| 2017-08-28 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Reiterato | Oppenheimer | Outperform |
| 2015-10-26 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Reiterato | Oppenheimer | Outperform |
| 2015-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Reiterato | Oppenheimer | Outperform |
| 2014-09-23 | Reiterato | Oppenheimer | Outperform |
| 2014-06-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Reiterato | Oppenheimer | Outperform |
| 2013-09-10 | Reiterato | Deutsche Bank | Hold |
| 2011-03-04 | Reiterato | Barclays Capital | Underweight |
| 2011-02-17 | Reiterato | Oppenheimer | Outperform |
| 2011-02-17 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Chemed Corp Borsa (CHE) Ultime notizie
Quietly essential in a crisis, Roto-Rooter Water Restoration goes beyond clogged drains - AD HOC NEWS
Chemed StockThursday technicals and trading range - AD HOC NEWS
Chemed Corp (CHE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Chemed Corp (CHE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Chemed Corp (CHE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Chemed Corp (CHE) Institutional Confidence - TradingKey
Chemed Corp (CHE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Chemed Corp (CHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Epoch Investment Partners Inc. Has $137.95 Million Stock Position in Chemed Corporation $CHE - MarketBeat
(CHE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Director Andrea Lindell Sells 1,347 Shares of Chemed Corp (CHE) - GuruFocus
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. By Investing.com - Investing.com South Africa
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. - Investing.com
Director Lindell sells 1,347 Chemed (NYSE: CHE) shares at $447.33 - Stock Titan
Roto-Rooter Services Company Acquires South Texas Franchise for $12 Million - Quiver Quantitative
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas - GlobeNewswire
Chemed Corp (CHE) Stock Analysis: A Robust Healthcare Play With Solid Financial Metrics - DirectorsTalk Interviews
ETFs Investing in Chemed Corporation Stocks - TradingView
VITAS CEO: CMS’ National Moratorium Disappointing - Hospice News
TD Asset Management Inc Has $138.86 Million Stock Holdings in Chemed Corporation $CHE - MarketBeat
CHE News | CHEMED CORP (NYSE:CHE) - ChartMill
Activist Barington targets healthcare firm Chemed - MSN
Chemed Corp (CHE) Moves Higher as Stock Tests Technical Resistance LevelsComposite Profile - newsline.com
Activist Barington Targets Healthcare Firm Chemed - Bloomberg.com
Chemed edges higher on report activist Barington has taken a stake - Seeking Alpha
CHE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (CHE) Movements Inform Risk Allocation Models - Stock Traders Daily
Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside - DirectorsTalk Interviews
Chemed Corp (CHE) Remains in Consolidation Near Key Resistance, Down 0.84%Inside Day Breakout - newsline.com
CHE Technical Analysis & Stock Price Forecast - Intellectia AI
Chemed director Walsh sells $218,915 in stock By Investing.com - Investing.com Australia
Chemed Corp (CHE) Shares Fall 3.1% -- What GF Score of 78 Tells Investors - GuruFocus
Chemed director Walsh sells $218,915 in stock - Investing.com
Chemed (NYSE: CHE) director sells 500 shares in open-market trade - Stock Titan
CHE Q1 2026 Earnings: EPS Beats Estimates by 5.5%Pre-Earnings Drift - thelegaladvocate.com
Chemed Corp (CHE) Edges Higher Amid Steady Trading: Key Levels to WatchMA Crossover - The Legal Advocate
Chemed Corp (CHE) Q1 2026 Earnings: EPS Beats Expectations Amid Strong Operational PerformanceRevenue Surprise History - The Legal Advocate
Chemed Corp (CHE) Holds Steady Near Support Amid Narrow Trading RangeSupply Zone - The Legal Advocate
Chemed Corp (CHE) Stock Report: Navigating Valuation with a 25.60% ROE and a Modest Upside - DirectorsTalk Interviews
Trading Systems Reacting to (CHE) Volatility - Stock Traders Daily
Chemed Corporation 8-K SEC Filing Summary for May 18, 2026 – Key Entity Information and Voting Results - Minichart
Chemed stockholders elect board, ratify auditor, reject executive pay plan - Investing.com
Shareholders at Chemed (NYSE: CHE) vote down pay plan but back board - Stock Titan
Chemed (NYSE: CHE) director awarded 386 shares of company stock - Stock Titan
Chemed (NYSE: CHE) director granted 386 capital shares in stock award - Stock Titan
CHEMED CORP (CHE) director receives 386-share equity award at $440.77 value - Stock Titan
Chemed (NYSE: CHE) director receives stock award, boosting holdings to 5,925 shares - Stock Titan
Director at Chemed (NYSE: CHE) receives 386-share stock award - Stock Titan
CHEMED (NYSE: CHE) director Ron DeLyons granted 386 shares of stock - Stock Titan
Chemed Corporation Stockholders Elect Directors, Ratify Accountants, and Declare Quarterly Dividend - Quiver Quantitative
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend - GlobeNewswire
Chemed Corp Azioni (CHE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.83%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):